Researchers have shown that new, or “de novo,” protein-altering mutations — genetic errors that are present in patients but not in their parents — play a role in more than 50 percent of “sporadic” — i.e., not hereditary — cases of schizophrenia.
Researchers have shown that new, or “de novo,” protein-altering mutations — genetic errors that are present in patients but not in their parents — play a role in more than 50 percent of “sporadic” — i.e., not hereditary — cases of schizophrenia.